Impaired dopamine release and uptake in R6/1 Huntington's disease model mice

被引:27
|
作者
Ortiz, Andrea N. [1 ,2 ]
Kurth, Benjamin J. [1 ,2 ]
Osterhaus, Gregory L. [1 ,2 ]
Johnson, Michael A. [1 ,2 ,3 ]
机构
[1] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA
[2] RN Adams Inst Bioanalyt Chem, Lawrence, KS 66045 USA
[3] Neurosci Program, Lawrence, KS 66045 USA
关键词
Dopamine; Voltammetry; Huntington's disease; R6/1; mice; Release; Uptake; MOUSE MODEL; GENE; DYSFUNCTION; REPEAT; EXON-1;
D O I
10.1016/j.neulet.2011.01.036
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease (HD) is a progressive, neurodegenerative movement disorder. Here, we used fast-scan cyclic voltammetry to measure dopamine release and uptake in striatal brain slices from R6/1 HD model mice. Peak dopamine release ([DA](max)) was significantly diminished in R6/1 mice (52% of wild-type at 24 weeks of age). Similarly, dopamine released per locally applied electrical stimulus pulse ([DA](p)), which is [DA](max) corrected for uptake and electrode performance, was also diminished in R6/1 mice (43% of wild-type by 24 weeks of age). Moreover, V-max, the maximum rate of dopamine uptake, obtained by modeling the stimulated release plots, was decreased at 16 and 24 weeks of age in R6/1 mice (51 and 48% of wild-type, respectively). Thus, impairments in both dopamine release and uptake appear to progress in an age-dependent manner in R6/1 mice. (C) 2011 Published by Elsevier Ireland Ltd.
引用
收藏
页码:11 / 14
页数:4
相关论文
共 50 条
  • [31] Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's disease
    Acevedo-Torres, Karina
    Berrios, Lexsy
    Rosario, Nydia
    Dufault, Vanessa
    Skatchkov, Serguei
    Eaton, Misty J.
    Torres-Ramos, Carlos A.
    Ayala-Torres, Sylvette
    DNA REPAIR, 2009, 8 (01) : 126 - 136
  • [32] Behavioural state differentially engages septohippocampal cholinergic and GABAergic neurons in R6/1 Huntington's disease mice
    Ransome, Mark I.
    Hannan, Anthony J.
    NEUROBIOLOGY OF LEARNING AND MEMORY, 2012, 97 (02) : 261 - 270
  • [33] Neuropeptide Y modifies the disease course in the R6/2 transgenic model of Huntington's disease
    Decressac, M.
    Wright, B.
    Tyers, P.
    Gaillard, A.
    Barker, R. A.
    EXPERIMENTAL NEUROLOGY, 2010, 226 (01) : 24 - 32
  • [34] Calcium dysregulation and compensation in cortical pyramidal neurons of the R6/2 mouse model of Huntington's disease
    Oikonomou, Katerina D.
    Donzis, Elissa J.
    Bui, Minh T. N.
    Cepeda, Carlos
    Levine, Michael S.
    JOURNAL OF NEUROPHYSIOLOGY, 2021, 126 (04) : 1159 - 1171
  • [35] Increased metabolism in the R6/2 mouse model of Huntington's disease
    van der Burg, Jorien M. M.
    Bacos, Karl
    Wood, Nigel I.
    Lindqvist, Andreas
    Wierup, Nils
    Woodman, Ben
    Wamsteeker, Jaclyn I.
    Smith, Ruben
    Deierborg, Tomas
    Kuhar, Michael J.
    Bates, Gillian P.
    Mulder, Hindrik
    Erlanson-Albertsson, Charlotte
    Morton, A. Jennifer
    Brundin, Patrik
    Petersen, Asa
    Bjorkqvist, Maria
    NEUROBIOLOGY OF DISEASE, 2008, 29 (01) : 41 - 51
  • [36] Cardiac dysfunction in the R6/2 mouse model of Huntington's disease
    Mihm, Michael J.
    Amann, Deborah M.
    Schanbacher, Brandon L.
    Altschuld, Ruth A.
    Bauer, John Anthony
    Hoyt, Karl R.
    NEUROBIOLOGY OF DISEASE, 2007, 25 (02) : 297 - 308
  • [37] Effects of a Sativex-Like Combination of Phytocannabinoids on Disease Progression in R6/2 Mice, an Experimental Model of Huntington's Disease
    Valdeolivas, Sara
    Sagredo, Onintza
    Delgado, Mercedes
    Pozo, Miguel A.
    Fernandez-Ruiz, Javier
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (04)
  • [38] Rigidity in social and emotional memory in the R6/2 mouse model of Huntington's disease
    Ciarnei, Alessandro
    Morton, A. Jennifer
    NEUROBIOLOGY OF LEARNING AND MEMORY, 2008, 89 (04) : 533 - 544
  • [39] Age-Dependent Degradation of Locomotion Encoding in Huntington's Disease R6/2 Model Mice
    Yamin, Hagar G.
    Menkes-Caspi, Noa
    Stern, Edward A.
    Cohen, Dana
    JOURNAL OF HUNTINGTONS DISEASE, 2021, 10 (03) : 391 - 404
  • [40] The GRP78-PERK axis contributes to memory and synaptic impairments in Huntington's disease R6/1 mice
    Espina, Marc
    Di Franco, Nadia
    Branas-Navarro, Martina
    Navarro, Irene Rodriguez
    Brito, Veronica
    Lopez-Molina, Laura
    Costas-Insua, Carlos
    Guzman, Manuel
    Gines, Silvia
    NEUROBIOLOGY OF DISEASE, 2023, 184